Can Fite Biopharma Ltd Cash Flow-to-Debt Ratio
Can Fite Biopharma Ltd cash flow-to-debt ratio. Can Fite Biopharma Ltd (CANF) has a Cash Flow-to-Debt Ratio of -0.67x as of June 2025, meaning its operating cash flow of ILA-2.38 Million could theoretically repay -1% of its total liabilities (ILA3.54 Million) in one year. See financial agility of Can Fite Biopharma Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Can Fite Biopharma Ltd (2010–2025)
Cash flow-to-debt ratio of Can Fite Biopharma Ltd from 2010 to 2025. Historical debt coverage capacity for Can Fite Biopharma Ltd across 16 annual periods. Check Can Fite Biopharma Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Can Fite Biopharma Ltd Cash Flow-to-Debt Ratio by Year (2010–2025)
Can Fite Biopharma Ltd cash flow-to-debt ratio by year from 2010 to 2025. Year-by-year debt coverage analysis for Can Fite Biopharma Ltd. For the full cash flow conversion analysis, see Can Fite Biopharma Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.47x | ILA-9.69 Million | ILA3.92 Million | ▼ -19.1% |
| 2024 | -2.07x | ILA-7.64 Million | ILA3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | ILA-8.44 Million | ILA3.75 Million | ▼ -0.4% |
| 2022 | -2.25x | ILA-10.80 Million | ILA4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | ILA-9.86 Million | ILA5.87 Million | ▲ +52.0% |
| 2020 | -3.50x | ILA-12.06 Million | ILA3.45 Million | ▼ -85.0% |
| 2019 | -1.89x | ILA-10.83 Million | ILA5.73 Million | ▼ -124.6% |
| 2018 | -0.84x | ILA-4.16 Million | ILA4.94 Million | ▲ +57.8% |
| 2017 | -1.99x | ILA-9.52 Million | ILA4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | ILA-8.93 Million | ILA6.29 Million | ▼ -118.2% |
| 2015 | -0.65x | ILA-4.65 Million | ILA7.16 Million | ▲ +70.5% |
| 2014 | -2.20x | ILA-7.33 Million | ILA3.33 Million | ▲ +44.5% |
| 2013 | -3.97x | ILA-8.63 Million | ILA2.18 Million | ▼ -113.7% |
| 2012 | -1.86x | ILA-4.35 Million | ILA2.34 Million | ▲ +45.6% |
| 2011 | -3.41x | ILA-5.50 Million | ILA1.61 Million | ▼ -410.8% |
| 2010 | -0.67x | ILA-3.65 Million | ILA5.47 Million | — |